Richard Hargis – Employee Spotlight
Meet Richard Hargis – Sr. Director, Drug Product Manufacturing at Argonaut What’s a day in the life of a Drug Product Manufacturing Director at Argonaut?
Category: Drug Product Manufacturing
Is Your CMO Holding You Back? Choosing the Right CMO for Biopharma Growth
4 Tips on choosing the right CMO for your biopharmaceutical For today’s biopharmaceutical manufacturers, time is of the essence. From overcoming evolving supply chain obstacles
Optimizing Fill and Finish: Key Takeaways from the KBI and Argonaut Webinar
In the evolving landscape of biopharmaceutical manufacturing, optimizing fill and finish plays a critical role in ensuring product quality, regulatory compliance, and operational efficiency. C-level executives looking to streamline
Why Reshoring Pharmaceutical and Life Science Manufacturing to the U.S. Makes Business Sense
Choosing a Contract Manufacturing Partner as a Smart Strategy Reshoring Pharmaceutical and Life Science manufacturing to the U.S. over the next four years presents
Steve Folio – Employee Spotlight
Meet Steve Folio – Vice President of Quality and Regulatory Affairs at Argonaut What does your role at Argonaut look like? “As Vice President
Risk Evaluation in Pharmaceutical Fill/Finish Sourcing
Tips for Risk Evaluation in Pharmaceutical Fill/Finish Sourcing In this post we focus on the critical decision pharmaceutical companies face regarding their fill/finish needs: whether
Entrepreneurial Insights from Wayne Woodard, CEO of Argonaut Manufacturing Services on “Executing the Vision”
In the latest episode of Executing the Vision, Brad Hunter of Emerge Labs interviews Wayne Woodard, CEO of Argonaut Manufacturing Services, who shares his journey from
Overcoming Challenges in Combination Product Manufacturing
Addressing novel modalities create the largest challenges in combination product manufacturing. Challenges in combination product manufacturing must overcome what has traditionally been two different manufacturing
Abzena and Argonaut Partner to Offer Accelerated End-to-End Drug Development Support for Biopharmaceutical Companies
Biopharma gains a seamless transition from drug discovery through drug product manufacturing San Diego, CA, June 20, 2024 – Abzena, the leading end-to-end integrated contract
Five Advantages of Dual-Sourcing in Pharmaceutical Fill/Finish – Understanding the Imperative
How resilient is your manufacturing strategy in the face of potential disruptions to the pharmaceutical supply chain? As we navigate the complex landscape of aseptic